Found 1070 chains in Genus chains table. Displaying 1 - 50. Applied filters: Proteins

Search results query: Retinoid X Receptor

Total Genus Sequence Length pdb Title
84 385 4nqaB Crystal structure of liganded hrxr-alpha/hlxr-beta heterodimer on dna
97 320 4iqrA Multi-domain organization of the hnf4alpha nuclear receptor complex on dna
111 371 3e00D Intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with gw9662, 9-cis retinoic acid and ncoa2 peptide
79 324 3e00A Intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with gw9662, 9-cis retinoic acid and ncoa2 peptide
91 324 3dzuA Intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with bvt.13, 9-cis retinoic acid and ncoa2 peptide
83 324 3dzyA Intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with rosiglitazone, 9-cis retinoic acid and ncoa2 peptide
102 370 3dzyD Intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with rosiglitazone, 9-cis retinoic acid and ncoa2 peptide
104 370 3dzuD Intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with bvt.13, 9-cis retinoic acid and ncoa2 peptide
94 242 3up0A Nuclear receptor daf-12 from hookworm ancylostoma ceylanicum in complex with (25s)-delta7-dafachronic acid
91 269 3s9sA Ligand binding domain of ppargamma complexed with a benzimidazole partial agonist
93 225 5m96A Synthesis and biological evaluation of new triazolo and imidazolopyridine rorgt inverse agonists
94 299 5lgaA Structural analysis and biological activities of bxl0124, a gemini analog of vitamin d
88 244 5lwpA Discovery of phenoxyindazoles and phenylthioindazoles as rorg inverse agonists
95 248 5l7gA Mcr in complex with ligand
99 248 5l7eA Mcr in complex with ligand
94 245 5krcA Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with zearalenone
90 246 5kr9A Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with coumestrol
79 244 5krkA Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with 4,4'-((5-bromo-2,3-dihydro-1h-inden-1-ylidene)methylene)diphenol
87 243 5kroA Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the methyl(phenyl)amino-substituted estrogen, (8r,9s,13s,14s,17s)-13-methyl-17-(methyl(phenyl)amino)-7,8,9,11,12,13,14,15,16,17-decahydro-6h-cyclopenta[a]phenanthren-3-ol
86 244 5krhA Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with 16-benzylidene estrone
91 244 5krlA Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the a-cd ring estrogen, (1s,7as)-5-(2-chloro-4-hydroxyphenyl)-7a-methyl-2,3,3a,4,7,7a-hexahydro-1h-inden-1-ol
84 245 5krjA Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with an a-naphthyl substituted obhs derivative
89 244 5kriA Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with 16b-benzyl 17b-estradiol
92 237 5l11A Human liver receptor homologue-1 (lrh-1) bound to rjw100 and a fragment of tif-2
88 245 5krmA Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the a-cd ring estrogen, (1s,7as)-5-(2,5-difluoro-4-hydroxyphenyl)-7a-methyl-2,3,3a,4,7,7a-hexahydro-1h-inden-1-ol
95 260 5kyjA Brain penetrant liver x receptor (lxr) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core
88 244 5kd9A Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with an n-trifluoroethyl 4-chlorobenzyl obhs-n derivative
92 235 5k13A Crystal structure of the rar alpha ligand-binding domain in complex with an antagonist
87 245 5kcwA Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with an n-trifluoroethyl obhs-n derivative
81 244 5kccA Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with oxabicyclic heptene sulfonamide (obhs-n)
98 252 5jjmA Crystal structure of homodimeric androgen receptor ligand-binding domain bound to dht and lxxll peptide
91 246 5kctA Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with an n-ethyl, 4-chlorobenzyl obhs-n derivative
80 240 5jy3A Crystal structure of lxrbeta (nuclear receptor subfamily 1, group h, member 2) complexed with bms-852927
82 243 5kcuA Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with an n-ethyl, alpha-naphthyl obhs-n derivative
85 247 5kceA Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with an n-methyl, 2-chlorobenzyl obhs-n derivative
92 244 5kcdA Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with an n-methyl substituted obhs-n derivative
90 247 5kcfA Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with an n-ethyl, 4-methoxybenzyl obhs-n derivative
99 251 5jjmB Crystal structure of homodimeric androgen receptor ligand-binding domain bound to dht and lxxll peptide
84 219 5ixkA Rorgamma in complex with inverse agonist bio399.
90 228 5iawA Novel natural fxr modulator with a unique binding mode
102 260 5i4vA Discovery of novel, orally efficacious liver x receptor (lxr) beta agonists
85 243 5hyrA Estrogen receptor alpha ligand binding domain y537s mutant in complex with stapled peptide src2-sp2 and estradiol
96 267 5hykA Crystal structure of the complex pparalpha/al26-29
95 268 5hzcA Crystal structure of the complex ppargamma/al26-29
89 250 5h1eA Interaction between vitamin d receptor and coactivator peptide src2-3
98 261 5hjpB Identification of lxrbeta selective agonists for the treatment of alzheimer's disease
72 250 5hjpA Identification of lxrbeta selective agonists for the treatment of alzheimer's disease
98 272 4ci5A Structural basis for gl479 a dual peroxisome proliferator-activated receptor gamma agonist
92 241 5c4oA Identification of a novel allosteric binding site for rorgt inhibitors
93 241 5c4tA Identification of a novel allosteric binding site for rorgt inhibitors